Patent licensing (B2B)

At Bioithas we carry out strict and rigorous clinical trials, mainly to validate probiotic products indicated and designed for improving people’s health and wellbeing.

The patents available at Bioithas are listed below:


Probiotic mixtures with proven efficacy for skin diseases

Probiotic for Atopic Dermatitis
Read more

Probiotic for Psoriasis
Read more

Probiotic for Acné
Read more

Probiotic for other skin diseases: consult for more information.


Probiotic mixtures for other pathologies

Probiotic for COVID-19


Microbiota-based diagnostic kits (biomarkers)

Multiple sclerosis
Read more

Head and neck cancer
Read more

Both the Atopic Dermatitis and Psoriasis probiotic products have been licensed in more than 30 countries. The same  for the Acne product.

If you are a pharmaceutical laboratory and are interested in obtaining a licence for any of these patents or require more information on any of them, please contact us and we will be happy to provide you with more information.

Step by step


Our methodology is based on:


A preliminary, broad and exhaustive study of the human microbiota to identify diseases that are likely to respond to treatment with probiotics that use this altered microbiota as a target.


The next step is to develop probiotics that are able to modulate this microbiota, improving patients' symptoms and consequently their quality of life.


We also use these data to develop biomarkers for early diagnosis of disease; these biomarkers can also be used to predict the response to treatment for a specific pathology based on such microbiota data.

Our competitive advantage advantage is the fact that we treat probiotics as medicinal products, thus putting great scientific rigour into all the products we develop.

Why license your patent with Bioithas?

In the vast majority of cases, the results of our research are published in high impact factor journals. This gives our product recognition and acceptance within the medical field, thus representing an enormous commercial capacity. Therefore, the product, whether a probiotic or a development for an early diagnostic biomarker, is patented nationally and internationally for further exploitation.

Within this line of business we own several patents and developments that can be licensed to third parties through the business-to-business (B2B) model.

Within the probiotics line, our expertise is focused on skin pathology, but we also have conducted numerous trials and gained extensive experience in digestive, immune, neurological and infectious pathologies.

If you have already decided, please fill in the following form.

Patent License Application

Fill in your details and we will contact you to discuss the license you are interested in.

    All personal data that you submit us via this form will be processed by Data Controller BIOITHAS, S.L. and saved into CONTACTS processing activitie, with the purpose of answering your inquiry, via email or phone, and for a later follow up.

    Processing shall be lawful because you give us your consent for these specific purposes. Your personal data will not be disclosed to third parties unless forced by law. You have right to access to, rectify, or delete your personal data, and other rights as explained in our Privacy Policy:

    Our accreditations

    Innovative SME Seal
    Innovative Technology-Based Enterprise (EIBT) Seal